We are thrilled to announce that Yolande Du Toit, MD, has joined Olema Oncology as our new Vice President of Medical Affairs! Dr. Du Toit brings a wealth of knowledge and medical affairs leadership in oncology and breast cancer. She has led critical projects and programs in breast cancer making a significant impact on patient care. We are excited to welcome her expertise as we continue to work towards advancing the standard of care for women living with breast cancer. Read more here: https://bit.ly/3xoH8RW #OntoSomethingBigTogether
About us
Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. Our lead program, palazestrant, a potential best-in-class complete estrogen receptor antagonist (CERAN), is in development to treat estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. It is being evaluated both as a single agent in an ongoing Phase 3 clinical trial, OPERA-01, and in Phase 1/2 combination studies with CDK4/6 inhibitors (palbociclib and ribociclib), a PI3Ka inhibitor (alpelisib), and an mTOR inhibitor (everolimus). We are supported in our mission by experienced and accomplished scientists and board members, leading healthcare investors and some of the most innovative pharma companies. For more information about the company please visit www.olema.com. Note: Olema will not conduct interviews via text message or messaging platforms and will not ask you to download anything as part of your interview. Though we use third party tools to help with advertising our jobs, please be vigilant in checking that the communication is in fact coming from Olema.
- Website
-
http://olema.com
External link for Olema Oncology
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- San Francisco, California
- Type
- Public Company
- Founded
- 2007
- Specialties
- pharmaceuticals, biotechnology, drug development, oncology, breast cancer, nuclear receptors, and small molecules
Locations
-
Primary
780 Brannan St
San Francisco, California 94103, US
-
101 Rogers St
3B
Cambridge, Massachusetts 02142, US
Employees at Olema Oncology
-
Geoffrey Mogilner
-
David Kwasha
Chief Executive Officer at AHAA! (Avril Henry and Associates) Pty Ltd
-
Krishna Singh
Helping pharmaceutical company to navigate clinical trials with GxP quality, regulatory compliance and inspection readiness.
-
Yi Larson
C-suite executive, Board Member and Audit Chair at RayzeBio, Board Member at Olema Oncology
Updates
-
Cheers to another fantastic summer with an amazing group of #Interns! Your hard work and collaboration have made a lasting impact on our team. We're excited to see where your journey takes you next! #OntoSomethingBigTogether
-
Join Olema as a Senior Director of Quality Assurance! In this role, you will lead GXP quality activities and systems to support our innovative cancer therapies. If you're passionate about making a difference in women's cancer treatment and have extensive QA experience in biotech/pharma, apply today: https://bit.ly/4chzev1 #OntoSomethingBigTogether #Hiring #NowHiring #BiotechJobs #QAJobs #QualityAssurance #WomensOncology #BreastCancer #BreastCancerResearch
-
$OLMA: We announced our Q2’24 financial results today with continued momentum from our recent palazestrant-ribociclib combo data update, our ongoing OPERA-01 trial, and upcoming milestones for both palazestrant and OP-3136, our KAT6 inhibitor. For more information, please see our release at https://bit.ly/4dvfLYW #OntoSomethingBigTogether
-
Join us in welcoming our new hires, Kitzie Lee Oliveira Zeidan, Brian Hudak, Wendy Wang, and Srini Jayaraman! We can't wait to celebrate your accomplishments at Olema. Join our team! See our open positions today: https://bit.ly/3yeTOyv #OntoSomethingBigTogether
-
We’re continuing our #NationalInternDay celebration by spotlighting our #SanFrancisco interns! We’re appreciative of their hard work, dedication, and the contributions they make every day. Swipe to hear about their experience. #OntoSometingBigTogether #Internship #SummerInternship
-
It's #NationalInternDay! We’re excited to have our #Boston interns with us this summer as we work together to transform the standard of care for women with cancer. Swipe to read their stories. #OntoSometingBigTogether #Internship #SummerInternship
-
In November 2020, Gopinath Palanisamy embarked on his journey with Olema, and today, he serves as our Vice President of Pre-Clinical Pharmacology and Toxicology. With a rich background in non-clinical drug development, Dr. Palanisamy has been instrumental in driving our mission forward, leveraging his extensive experience as a scientist, toxicologist, and American board-certified veterinary pathologist. Discover Dr. Palanisamy's remarkable career path in #Biotech and explore the exciting opportunities at Olema. Apply today: https://bit.ly/3xFFDlL #OntoSomethingBigTogether
-
Your talent can make a difference! Help us work to improve the lives of women battling cancer. Apply to join our team today: https://bit.ly/3zIEv16 #OntoSomethingBigTogether #ClinicalScience #BioTechJobs #CMC #ClinicalSupplyChain #WomensOncology #Oncology #ClinicalDevelopment
-
Welcoming the next generation of innovators! At Olema, we're excited to welcome our dynamic team of summer interns who are passionate, driven, and ready to make a difference. 📸: Elena D., Haley Roach, Sachi Jauhari, Maleeha Madinawala, Aryav Yadapadithaya, Caroline K., Helen L. Yang, and Conley Konsin. #OntoSomethingBigTogether #Internship #SummerInternship